AnaptysBio (ANAB) stock climbs as its antibody therapy rosnilimab meets key goals in mid-stage rheumatoid arthritis trial, ...
Clinical Trials Arena on MSN19h
Trump’s tariffs will trickle down the clinical trial chainTariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.
Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...
Zacks Investment Research on MSN5d
Here's Why You Should Retain Glaukos Stock in Your Portfolio NowGlaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback